ArticleCanadian journal of anaesthesia = Journal canadien d'anesthesie2026
Effects of sevoflurane on natural killer cell-induced apoptosis of malignant tumour cells: an in vitro laboratory study.
Article in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeNatural killer (NK) cells contribute to tumour immunosurveillance. They detect and eliminate circulating tumour cells by degranulation, releasing perforin and granzyme. Also involved in NK-cell-mediated tumour cell defense are cytokines with proapoptotic and anti-apoptotic characteristics as well as extracellular vesicles containing perforin. Recent clinical studies suggest that volatile anesthetics might negatively impact cancer outcomes compared with intravenous agents. A possible factor could be the impairment of NK cell activity by volatile anesthetics. In this study, we aimed to investigate the effects of sevoflurane on NK-mediated tumour cell defense in a cell model in vitro.
methodsIn an in vitro laboratory study, we exposed a NK cell line to 2.2% sevoflurane for 2 hr, followed by co-incubation with leukemia target cells. We defined apoptosis of targeted tumour cells and explored effector cell mechanisms by assessing degranulation of NK92 cells and production of cytokine messenger ribonucleic acid (mRNA). Furthermore, we determined NK cell concentrations of extracellular vesicles and perforin protein.
resultsAfter 24 hr of co-incubation of tumour cells with sevoflurane-pretreated NK cells, the number of early apoptotic tumour cells was decreased, with a reduction of 36% on average (P = 0.016). Natural killer cell degranulation, cytokine mRNA, and size and concentration of extracellular vesicles were not significantly different. The perforin concentration of NK cells was reduced when pretreated with sevoflurane. At 48 hr, perforin cell content as well as perforin in the supernatant was reduced (mean reduction for both, 16%; P < 0.001 for both).
conclusionsThis study suggests that the observed transient impaired NK-cell-mediated tumour defense may be linked to the reduced perforin production when NK cells are exposed to sevoflurane.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.